Suppr超能文献

升级为左束支区域起搏在起搏诱导性心肌病或非起搏诱导性心肌病相关升级状态患者中的具体价值:一项回顾性研究。

The specific value of upgrading to left bundle branch area pacing in patients with pacing-induced cardiomyopathy or non-pacing-induced cardiomyopathy related upgrade status: A retrospective study.

机构信息

Department of Cardiology, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.

Key Laboratory of Cardiovascular Intervention and Regenerative Medicine of Zhejiang Province, Hangzhou, China.

出版信息

Pacing Clin Electrophysiol. 2023 Jul;46(7):761-770. doi: 10.1111/pace.14723. Epub 2023 May 29.

Abstract

AIMS

Left bundle branch area pacing (LBBaP) upgrade can improve cardiac function and clinical outcomes in patients with pacing-induced cardiomyopathy (PICM), but the specific value of LBBaP upgrade, especially compared with the cardiac function level before right ventricular pacing (RVP) in patients with PICM and non-pacing-induced cardiomyopathy-related upgrade status (Non-PICMUS) is still unknown.

METHODS

This study retrospectively enrolled 70 patients with LBBaP upgrade (38 patients with PICM and 32 patients with Non-PICMUS). All upgrade patients experienced three stages: before RVP (Pre-RVP), before LBBaP upgrade (Pre-LBBaP), and after LBBaP upgrade (Post-LBBaP). QRS duration (QRSd), lead parameters, echocardiographic indicators, and clinical outcomes evaluation were recorded at multiple time points.

RESULTS

At the follow-up of 12 months, for PICM patients, left ventricular ejection fraction (LVEF) significantly increased from 36.6% ± 7.2% to 51.3% ± 8.7% Post-LBBaP (p < .001), and left ventricular end-diastolic diameter (LVEDD) significantly decreased from 61.5 ± 6.4 mm to 55.2 ± 6.5 mm Post-LBBaP (p < .001), but they both failed to restore the level Pre-RVP (both p < .001). For PICM patients, New York Heart Association (NYHA) classification, the number of moderate-to-severe heart failure (NYHA III-IV), and diuretics using rate after the LBBaP upgrade also could not restore to the level Pre-RVP (all p < .001). At the follow-up of 12 months, Non-PICMUS patients after the LBBaP upgrade had no significant improvement in LVEF, LVEDD, and NYHA classification (all p > .05).

CONCLUSION

LBBaP upgrade effectively improved the cardiac function and clinical outcomes in PICM patients, but its effectiveness seemed to be limited as the deteriorated cardiac function cannot be completely reversed. For Non-PICMUS patients, the cardiac function and clinical outcomes Post-LBBaP had no significant improvement.

摘要

目的

左束支区域起搏(LBBaP)升级可改善起搏诱导性心肌病(PICM)患者的心脏功能和临床结局,但 LBBaP 升级的具体价值,尤其是与 PICM 患者的右心室起搏(RVP)前心脏功能水平和非起搏诱导性心肌病相关升级状态(Non-PICMUS)相比,仍不清楚。

方法

本研究回顾性纳入 70 例接受 LBBaP 升级的患者(PICM 患者 38 例,Non-PICMUS 患者 32 例)。所有升级患者经历了三个阶段:RVP 前(Pre-RVP)、LBBaP 升级前(Pre-LBBaP)和 LBBaP 升级后(Post-LBBaP)。在多个时间点记录 QRS 时限(QRSd)、导联参数、超声心动图指标和临床结局评估。

结果

在 12 个月的随访中,对于 PICM 患者,左心室射血分数(LVEF)从 Pre-RVP 的 36.6%±7.2%显著增加至 Post-LBBaP 的 51.3%±8.7%(p<0.001),左心室舒张末期直径(LVEDD)从 Pre-RVP 的 61.5±6.4mm 显著降低至 Post-LBBaP 的 55.2±6.5mm(p<0.001),但均未恢复至 Pre-RVP 水平(均 p<0.001)。对于 PICM 患者,纽约心脏协会(NYHA)心功能分级、中重度心力衰竭(NYHA III-IV)的数量以及 LBBaP 升级后的利尿剂使用率也无法恢复至 Pre-RVP 水平(均 p<0.001)。在 12 个月的随访中,Non-PICMUS 患者在接受 LBBaP 升级后,LVEF、LVEDD 和 NYHA 分级均无显著改善(均 p>0.05)。

结论

LBBaP 升级可有效改善 PICM 患者的心脏功能和临床结局,但由于恶化的心脏功能无法完全逆转,其效果似乎有限。对于 Non-PICMUS 患者,Post-LBBaP 的心脏功能和临床结局无显著改善。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验